WallStSmart

BrightSpring Health Services, Inc. Common Stock (BTSG)vsDefinitive Healthcare Corp (DH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

BrightSpring Health Services, Inc. Common Stock generates 5627% more annual revenue ($13.65B vs $238.26M). BTSG leads profitability with a 2.3% profit margin vs -71.5%. BTSG earns a higher WallStSmart Score of 53/100 (C-).

BTSG

Buy

53

out of 100

Grade: C-

Growth: 8.7Profit: 5.0Value: 4.0Quality: 6.0
Piotroski: 5/9Altman Z: 2.65

DH

Hold

37

out of 100

Grade: F

Growth: 3.3Profit: 2.0Value: 6.7Quality: 4.5
Piotroski: 5/9Altman Z: -1.24
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BTSG.

DHUndervalued (+78.5%)

Margin of Safety

+78.5%

Fair Value

$7.87

Current Price

$0.76

$7.11 discount

UndervaluedFair: $7.87Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BTSG2 strengths · Avg: 9.0/10
EPS GrowthGrowth
359.8%10/10

Earnings expanding 359.8% YoY

Revenue GrowthGrowth
25.6%8/10

Revenue surging 25.6% year-over-year

DH1 strengths · Avg: 10.0/10
Price/BookValuation
0.5x10/10

Reasonable price relative to book value

Areas to Watch

BTSG4 concerns · Avg: 2.8/10
Profit MarginProfitability
2.3%3/10

2.3% margin — thin

Operating MarginProfitability
3.4%3/10

Operating margin of 3.4%

Debt/EquityHealth
1.363/10

Elevated debt levels

P/E RatioValuation
86.0x2/10

Premium valuation, high expectations priced in

DH4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$85.30M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.163/10

Elevated debt levels

Return on EquityProfitability
-116.5%2/10

ROE of -116.5% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : BTSG

The strongest argument for BTSG centers on EPS Growth, Revenue Growth. Revenue growth of 25.6% demonstrates continued momentum.

Bull Case : DH

The strongest argument for DH centers on Price/Book.

Bear Case : BTSG

The primary concerns for BTSG are Profit Margin, Operating Margin, Debt/Equity. A P/E of 86.0x leaves little room for execution misses. Thin 2.3% margins leave little buffer for downturns.

Bear Case : DH

The primary concerns for DH are EPS Growth, Market Cap, Debt/Equity.

Key Dynamics to Monitor

BTSG profiles as a growth stock while DH is a turnaround play — different risk/reward profiles.

BTSG carries more volatility with a beta of 1.87 — expect wider price swings.

BTSG is growing revenue faster at 25.6% — sustainability is the question.

BTSG generates stronger free cash flow (101M), providing more financial flexibility.

Bottom Line

BTSG scores higher overall (53/100 vs 37/100) and 25.6% revenue growth. DH offers better value entry with a 78.5% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

BrightSpring Health Services, Inc. Common Stock

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

BrightSpring Health Services, Inc. (BTSG) is a premier provider of home and community-based health services, dedicated to serving diverse patient populations, including those with intellectual and developmental disabilities, as well as individuals requiring rehabilitation. The company emphasizes personalized, high-quality care delivered by a skilled workforce, which has proven to enhance patient outcomes and overall quality of life. With strategic investments in innovative technologies and a commitment to value-based care, BrightSpring is strategically positioned to excel in the evolving healthcare landscape, leveraging growth opportunities in the sector.

Visit Website →

Definitive Healthcare Corp

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Definitive Healthcare Corp (DH) is a premier provider of comprehensive data and analytics solutions tailored for the healthcare sector, serving a broad spectrum of clients, including pharmaceutical firms, payers, and healthcare providers. The company leverages vast datasets and advanced real-time analytics to drive operational efficiency and provide strategic insights, ultimately enhancing patient outcomes. Positioned at the forefront of a rapidly evolving healthcare landscape, Definitive Healthcare is dedicated to delivering innovative, data-centric solutions that not only optimize operational performance but also confer competitive advantages to its partners. As demand for sophisticated healthcare analytics surges, DH is poised to be an influential player in redefining healthcare delivery.

Visit Website →

Want to dig deeper into these stocks?